Expression of the FMR1 gene

Cytogenetic and Genome Research

Volumn 100, Issue 1-4, 2003, Pages 124-128

  Tassone, F ^a   Hagerman, P J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA;

5' UNTRANSLATED REGION; ALLELE; FRAGILE X SYNDROME; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; MOSAICISM; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; TRINUCLEOTIDE REPEAT;

DNA METHYLATION; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; HETEROZYGOTE; HUMANS; MALE; MUTATION; NERVE TISSUE PROTEINS; RNA, MESSENGER; RNA-BINDING PROTEINS; SEX FACTORS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0344244911     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072846     Document Type: Review

References (33)

1. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, et al: Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study-preliminary data. Am J med Genet 83:322-325 (1999).
2. Burman RW, Yates PA, Green LD, Jacky PB, Turker MS, Popovich BW: Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect. Am J hum Genet 65: 1375-1386 (1999).
3. Coffee B, Zhang F, Warren ST, Reines D: Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nature Genet 22:98-101(1999).
4. Coffee B, Zhang F, Ceman S, Warren ST, Reines D: Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile X syndrome. Am J hum Genet 71:923-932 (2002).
5. De Vries BBA, Jansen CCAM, Duits AA, Verheij C, Willemsen R, van Hemel JO, van den Ouweland AMW, Niermeijer MF, Oostra BA, Halley DJJ: Variable FMR1 gene methylation of large expansions leads to variable phenotype in three males from one fragile X family. J med Genet 33:1007-1010 (1996).
6. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL: The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nature Genet 4:335-340 (1993).
7. Feng Y, Lakkis L, Devys D, Warren ST: Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J hum Genet 56:106-113 (1995a).
8. Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, Warren ST: Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731-734 (1995b).
9. Greco CM, Hagerman RJ, Tassone F, Chudley AE, Del Bigio MR, Jacquemont, Leehey M, Hagerman PJ: Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125:1760-1771 (2002).
10. Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, O'Connor, RA, Seydel C, Mazzocco MM, Snow K, Thibodeau SN, Kuhl D, Nelson DL, Cas-key TC, Taylor AK: High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J med Genet 51:298-308 (1994).
11. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grisby J, Gage B, Hagerman PJ: Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127-130 (2001).
12. Hagerman PJ, Greco CM, Hagerman RJ: A cerebellar tremor/ataxia syndrome among fragile X carriers. Cytogenet Genome Res 100:206-212 (2003).
13. Hornstra IK, Yang TP: Multiple in vivo footprints are specific to the active allele of the X-linked human hypoxanthine phosphoribosyltransferase gene 5′ region: implications for X chromosome inactivation. Mol Cell Biol 12:5345-5354 (1993).
14. Imbert G, Feng Y, Nelson D, Warren ST, Mandel JL: FMR1 and mutations in Fragile X syndrome: molecular biology, biochemistry, and genetics, in Wells RD, Warren, ST (eds): Genetic Instabilities and Hereditary Neurological Disorders, pp27-53 (Academic Press, San Diego 1998).
15. Jacquemont S, Hagerman RJ, Leehy M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ: Fragile X premutation tremor/ataxia syndrome: Molecular, clinical and neuroimaging correlates. Am J hum Genet 72:869-878 (2003).
16. Kaufmann WE, Abrams MT, Chen W, Reiss AL: Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome. Am J med Genet 83:286-295 (1999).
17. Kenneson A, Zhang F, Hagedorn CH, Warren ST: Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hummolec Genet 14:1449-1454 (2001).
18. Lachiewicz AM, Spiridigliozzi GA, McConkie-Rosell A, Burgess D, Feng Y, Warren ST, Tarleton J: A fragile X male with a broad smear on Southern blot analysis representing 100-500 CGG repeats and no methylation at the Eag1 site of the FMR1 gene. Am J med Genet 64:278-282 (1996).
19. Merenstein SA, Shyu V, Sobesky WE, Staley L, Berry-Kravis E, Nelson DL, Lugenbeel KA, Taylor AK, Pennington BF, Hagerman RJ: Fragile X syndrome in a normal IQ male with learning and emotional problems. J Am Acad Child Adolesc Psychiatry 33:1316-1321 (1994).
20. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL: Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822 (1991).
21. Primerano B, Tassone F, Hagerman RJ, Hagerman PJ, Amaldi F, Bagni C: Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA 8:1482-1488 (2002).
22. Rousseau F, Robb LJ, Rouillard P, Der Kaloustian VM: No mental retardation in a man with 40 % abnormal methylation at the FMR1 locus and transmission of sperm cell mutations as premutations. Hummolec Genet 3:927-930 (1994).
23. Smeets HJM, Smits APT, Verheij CE, Theelen JPG, Willemsen R, van de Burgt I, Hoogeveen AT, Oosterwijk, Oostra BA: Normal phenotype in two brothers with a full FMR1 mutation. Hum molec Genet 4:2103-2108 (1995).
24. Tassone F, Hagerman RJ, Ikle D, Dyer PN, Lampe M, Willemsen R, Oostra BA, Taylor AK: FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J med Genet 84:250-261 (1999a).
25. Tassone F, Hagerman RJ, Taylor AK, Gane LW, God-frey TE, Hagerman PJ: Elevated levels of FMR1 messenger RNA in carriers males: a new mechanism of involvement in the fragile X syndrome. Am J hum Genet 66:6-15 (2000a).
26. Tassone F, Hagerman RJ, Loesch DZ, Lachiewicz A, Taylor AK, Hagerman PJ: Fragile X males with unmethylated, full mutation trinucleotides repeat expansions and elevated levels of FMR1 messenger. Am J med Genet 94:232-236 (2000b).
27. Tassone F, Hagerman RJ, Chamberlain WD, Hagerman PJ: Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J med Genet 97:195-203 (2000c).
28. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, Hagerman PJ: Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J med Genet 91:144-152 (2000d).
29. Tassone F, Hagerman, RJ, Taylor, AK, Hagerman, PJ: A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J med Genet 38:453-456 (2001).
30. Taylor AK, Tassone F, Dyer PN, Hersch SM, Harris JB, Greenough WT, Hagerman RJ: Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome. Am J med Genet 84:233-239 (1999).
31. Verheij C, Bakker CE, de Graaff E, Keulemans J, Willemsen R, Verkerk AJ, Galjaard H, et al: Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363:722-724 (1993).
32. Wang Z, Taylor AK, Bridge JA: FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male. J med Genet 33:376-378 (1996).
33. Wohrle D, Salat U, Glaser D, Mucke J, Meisel-Stosiek M, Schindler D, Vogel W, Steinbach P: Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J Med Genet 35:103-111 (1998).